| scholarly article | Q13442814 |
| P50 | author | María Matilde Said | Q89272189 |
| P2093 | author name string | Ju Chen | |
| Julián Taranda | |||
| Jorge Scaglione | |||
| Kent C Lloyd | |||
| Cary Lai | |||
| Cecilia M Hertig | |||
| Hernán García-Rivello | |||
| Martin Vila-Petroff | |||
| Patricia Cabeza-Meckert | |||
| Ruben P Laguens | |||
| Sergio Ghio | |||
| P2860 | cites work | A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function | Q35895986 |
| Recent advances in gene mutagenesis by site-directed recombination | Q39763898 | ||
| Neuregulins in development | Q40943947 | ||
| Requirement for neuregulin receptor erbB2 in neural and cardiac development | Q41269625 | ||
| A post-transcriptional compensatory pathway in heterozygous ventricular myosin light chain 2-deficient mice results in lack of gene dosage effect during normal cardiac growth or hypertrophy. | Q41643409 | ||
| Synergistic roles of neuregulin-1 and insulin-like growth factor-I in activation of the phosphatidylinositol 3-kinase pathway and cardiac chamber morphogenesis | Q41708926 | ||
| The internal and external protein scaffold of the T-tubular system in cardiomyocytes | Q42463373 | ||
| ErbB2 is essential in the prevention of dilated cardiomyopathy. | Q43976647 | ||
| Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants | Q44451696 | ||
| Na(+)-Ca2+ exchange function underlying contraction frequency inotropy in the cat myocardium | Q44561649 | ||
| Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities. | Q50850337 | ||
| Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 | ||
| Untangling the ErbB signalling network | Q27860884 | ||
| Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress | Q28142513 | ||
| Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses | Q28145732 | ||
| Selective requirement of myosin light chain 2v in embryonic heart function | Q28258434 | ||
| Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling | Q28283670 | ||
| Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor | Q28509287 | ||
| Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt | Q28576264 | ||
| Multiple essential functions of neuregulin in development | Q28587914 | ||
| Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death | Q28591473 | ||
| Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy | Q28593656 | ||
| The Genetic Basis for Cardiomyopathy | Q29300961 | ||
| Derivation of completely cell culture-derived mice from early-passage embryonic stem cells | Q29547491 | ||
| Stress pathways and heart failure | Q33734297 | ||
| Specialization at the Z line of cardiac myocytes | Q33895501 | ||
| Molecular targets for breast cancer therapy and prevention | Q33944781 | ||
| Localization and modulation of ErbB receptor tyrosine kinases | Q34180606 | ||
| Neuregulin and ErbB receptor signaling pathways in the nervous system | Q34278032 | ||
| P433 | issue | 3 | |
| P921 | main subject | dilated cardiomyopathy | Q283656 |
| P304 | page(s) | H1153-60 | |
| P577 | publication date | 2005-04-29 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle | |
| P478 | volume | 289 |
| Q79861968 | "To erb-B or not to erb-B..." Neuregulin-1/ErbB signaling in heart development and function |
| Q36204959 | A specified therapeutic window for neuregulin-1 to regenerate neonatal heart muscle |
| Q30383554 | Activation of endothelial β-catenin signaling induces heart failure. |
| Q29347286 | Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy |
| Q34062716 | Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway |
| Q46503210 | Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction |
| Q39344380 | Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab |
| Q37833892 | Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. |
| Q37195581 | Chronic pharmacologic inhibition of EGFR leads to cardiac dysfunction in C57BL/6J mice |
| Q36219633 | Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse. |
| Q92677814 | Doxorubicin-Induced Cardiomyopathy in Children |
| Q36980191 | Effects of radiation on the epidermal growth factor receptor pathway in the heart |
| Q38831024 | Endothelial ErbB4 deficit induces alterations in exploratory behavior and brain energy metabolism in mice. |
| Q42101216 | Endothelium-derived neuregulin protects the heart against ischemic injury |
| Q37434706 | Epidermal Growth Factor Receptor Silencing Blunts the Slow Force Response to Myocardial Stretch |
| Q34545577 | ErbB signaling in cardiac development and disease |
| Q34411572 | ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation |
| Q83601013 | ErbB4 knockdown in serotonergic neurons in the dorsal raphe induces anxiety-like behaviors |
| Q35740039 | ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response |
| Q41197018 | ErbB4 signaling in the prelimbic cortex regulates fear expression |
| Q47679786 | Erbb4 Deletion from Medium Spiny Neurons of the Nucleus Accumbens Core Induces Schizophrenia-Like Behaviors via Elevated GABAA Receptor α1 Subunit Expression. |
| Q35836843 | Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling |
| Q34268994 | Genetic labeling reveals novel cellular targets of schizophrenia susceptibility gene: distribution of GABA and non-GABA ErbB4-positive cells in adult mouse brain. |
| Q38657925 | Genome-wide Association Study of Susceptibility to Particulate Matter-Associated QT Prolongation |
| Q92980782 | Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies |
| Q35776531 | Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone |
| Q34070488 | Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland |
| Q37189988 | Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes |
| Q47931199 | Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung. |
| Q35879939 | Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling. |
| Q36197691 | Molecular Characterization of Striated Muscle-Specific Gab1 Isoform as a Critical Signal Transducer for Neuregulin-1/ErbB Signaling in Cardiomyocytes |
| Q34806634 | Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. |
| Q39430235 | Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. |
| Q30480449 | Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. |
| Q48204966 | Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons |
| Q41812527 | Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes |
| Q26991903 | Neuregulin as a heart failure therapy and mediator of reverse remodeling |
| Q37118330 | Neuregulin in cardiovascular development and disease |
| Q37738659 | Neuregulin signaling and heart failure |
| Q28295209 | Neuregulin-1/ErbB signaling and chronic heart failure |
| Q27022965 | Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines |
| Q42969095 | Neuregulin-1beta1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes |
| Q53193638 | Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes. |
| Q57176905 | New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications |
| Q38594785 | New medical therapies for heart failure |
| Q46830543 | PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis |
| Q37072216 | PPARs and the kidney in metabolic syndrome |
| Q89967573 | Parvalbumin Interneuron Activation-Dependent Adult Hippocampal Neurogenesis Is Required for Treadmill Running to Reverse Schizophrenia-Like Phenotypes |
| Q30384457 | Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation. |
| Q30251531 | Potential new drug treatments for congestive heart failure |
| Q46760103 | Proteomic Analysis of Endothelin-1 Targets in the Regulation of Cardiomyocyte Proliferation |
| Q38193013 | ROS signalling between endothelial cells and cardiac cells |
| Q42911854 | Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents |
| Q34784347 | Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice. |
| Q34692233 | The epidermal growth factor receptor family: biology driving targeted therapeutics |
| Q37368662 | The growth factor receptor ERBB2 regulates mitochondrial activity on a signaling time scale |
| Q37155921 | The role of Neuregulin-1beta/ErbB signaling in the heart |
| Q40552347 | The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction |
| Q36042588 | The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation |
| Q40276214 | Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells |
| Q46245905 | Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure. |
| Q58700395 | miR-146a Attenuates Sepsis-Induced Myocardial Dysfunction by Suppressing IRAK1 and TRAF6 via Targeting ErbB4 Expression |
| Q90068727 | miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity |
Search more.